{"url":"https://newsforagent.com/news/2026-10-25/icu-corporation-preznel-dtx-strabismus","markdown_url":"https://newsforagent.com/news/2026-10-25/icu-corporation-preznel-dtx-strabismus.md","title":"ICU Corporation Develops XR Therapy for Childhood Strabismus","headline":"ICU Corporation Develops PREZNEL DTx XR Therapy for Pediatric Strabismus and Amblyopia","description":"ICU Corporation is developing PREZNEL DTx, an XR digital therapeutic for pediatric strabismus and amblyopia, with KRW 500 million in pre-Series A funding.","section":"Product Launches","published_at":"2026-10-25T03:31:13+00:00","modified_at":"2026-10-25T03:31:13+00:00","author":"News Desk","key_takeaways":["ICU Corporation is developing PREZNEL DTx, an XR-based digital therapeutic for pediatric strabismus and amblyopia that combines AI eye tracking with gamified VR training.","The company secured KRW 500 million in pre-Series A funding from AI Angel Club, Series Ventures, NVC Partners and CNTTech.","ICU Corporation is seeking KRW 3 billion in Series A funding and pursuing FDA approval and US commercialization."],"companies":[{"name":"ICU Corporation","is_primary":true,"profile_url":"https://akta.pro/company-profiles/0004ikh/icu-corporation","website":"http://www.icuvc.kr/#null"},{"name":"CNTTECH","is_primary":false,"profile_url":"https://akta.pro/company-profiles/0004oo6/cnttech","website":"https://www.cntt.co.kr"},{"name":"Series Ventures","is_primary":false,"profile_url":"https://akta.pro/company-profiles/0003dk8/series-ventures","website":"http://s-ventures.co.kr"}],"source":{"publisher":"Nate","title":"ICU Corporation Develops XR Digital Therapeutic for Pediatric Strabismus and Amblyopia : 네이트 뉴스","url":"https://news.nate.com/view/20261025n06847?mid=n0100"},"other_sources":[{"publisher":"Stock Titan","url":"https://www.stocktitan.net/news/MODD/modular-medical-launches-digital-learning-tools-to-support-adoption-u8itcut4cw3c.html"},{"publisher":"BusinessLine","url":"https://www.thehindubusinessline.com/companies/rewin-health-launches-platform-to-train-differently-abled-people-in-everyday-skills/article71582981.ece"}],"tags":["Product Launches","ICU Corporation","CNTTECH","Series Ventures"],"body_markdown":"[ICU Corporation](https://akta.pro/company-profiles/0004ikh/icu-corporation) is developing PREZNEL DTx, an XR-based digital therapeutic for pediatric strabismus and amblyopia that combines AI eye tracking with gamified VR training. The company said it has secured KRW 500 million in pre-[Series](https://akta.pro/company-profiles/0003dk8/series-ventures) A funding and is pursuing FDA approval and US commercialization. [Nate](https://news.nate.com/view/20261025n06847?mid=n0100) reported the development on October 25, 2026.\n\n## ICU Corporation's PREZNEL DTx at KIMES BUSAN 2026\n\nICU Corporation, led by CEO Donghyeok Kim, is presenting its AI, XR and eye-tracking digital healthcare solutions for pediatric visual dysfunction at the 14th KIMES BUSAN International Medical & Hospital Equipment Show (KIMES BUSAN 2026). The company said PREZNEL DTx uses AI-based eye tracking to measure squint angles and the degree of diplopia, and provides a digital therapeutic that stimulates and trains a patient's binocular vision and extraocular muscles in a virtual environment. The company said the solution extends care beyond surgery to mild-to-moderate cases and post-operative rehabilitation. Its business model runs on two tracks: treatment in the hospital and remote monitoring at home (ALY). The solution on show has four main features: objective assessment through AR/VR eye tracking, extraocular muscle control and visual training, gamified XR content, and AI data management and continuous care. The company said an exploratory clinical trial confirmed its therapeutic effect. ICU Corporation considers patient adherence a critical factor in vision rehabilitation, and its competitive strengths, it says, are immersive VR gamification content and AI-based real-time data monitoring. The platform targets parents in their 30s and 40s seeking a non-surgical, everyday treatment option for a child with strabismus, amblyopia or another vision problem, and university hospital pediatric ophthalmology departments, eye specialty hospitals and eye clinics that need objective diagnosis and digital rehabilitation. CNTTech, a South Korean fintech investment firm, invested in Tomoarrow and MakeWorks on August 10 to advance identity verification and CAD collaboration technologies, according to Wowtale.\n\n## ICU Corporation's Funding and Clinical Partnerships\n\nAccording to akta.pro [company records](https://akta.pro/company-data), ICU Corporation raised a pre-A round of 500 million KRW in 2024 and a seed round of 350 million KRW in 2023. The same records show a 2024-12 seed of $350,019 with 4 investors. ICU Corporation signed an MOU with Inje University Busan Paik Hospital in 2025 for academic-medical cooperation in ophthalmology and optometry clinical research. The company registered a patent in 2025 for a VR-based strabismus and skew deviation training system. It operates five centers as of 2025, including Changwon HQ, Busan Myeongji Center, Daegu Gyeongsan, Daegu Suseong, and Unicty Center, and targets 100 centers globally by 2028.\n\n## Digital Therapeutic Launches Across the Sector\n\nModular Medical launched two digital education resources on October 15, 2026, to help prospective users familiarize themselves with its Pivot insulin delivery system before formal training, [Stock Titan](https://www.stocktitan.net/news/MODD/modular-medical-launches-digital-learning-tools-to-support-adoption-u8itcut4cw3c.html) reported. The tools, developed with Relevate Health Games, include a 15-minute virtual walkthrough and a module in Level One: A Diabetes Game, which has been downloaded over 53,000 times. Rewin Health launched JADHU on October 14, 2026, an interactive platform with VR and AI exercises for differently-abled children and adults, [BusinessLine](https://www.thehindubusinessline.com/companies/rewin-health-launches-platform-to-train-differently-abled-people-in-everyday-skills/article71582981.ece) reported. The platform offers 30-minute sessions from over 200 games and will be provided free to 500 families in Tamil Nadu with ₹3 crore investment.\n\n## ICU Corporation's Next Steps for FDA Clearance\n\nICU Corporation plans to pursue domestic confirmatory clinical trials and MFDS approval, FDA clearance, US commercialization, global market expansion and then pipeline expansion. Following the FDA Pre-Submission process and 510(k) clearance, it plans to pursue B2B and B2G commercialization with local medical institutions in the US, then expand to Canada, Japan and China. It also plans to develop follow-on DTx products, including one for controlling the progression of myopia in children.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}